These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 34062788)
21. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium. Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028 [TBL] [Abstract][Full Text] [Related]
23. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma. Hammad TA; Thrift AP; El-Serag HB; Husain NS Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493 [TBL] [Abstract][Full Text] [Related]
24. Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression. Hamilton JP; Sato F; Jin Z; Greenwald BD; Ito T; Mori Y; Paun BC; Kan T; Cheng Y; Wang S; Yang J; Abraham JM; Meltzer SJ Clin Cancer Res; 2006 Nov; 12(22):6637-42. PubMed ID: 17121882 [TBL] [Abstract][Full Text] [Related]
25. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference. Zhou Z; Xia Y; Bandla S; Zakharov V; Wu S; Peters J; Godfrey TE; Sun J Hum Pathol; 2014 Aug; 45(8):1744-51. PubMed ID: 24951052 [TBL] [Abstract][Full Text] [Related]
26. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited. Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425 [TBL] [Abstract][Full Text] [Related]
27. Endoscopic imaging of Barrett's esophagus. Naveed M; Dunbar KB World J Gastrointest Endosc; 2016 Mar; 8(5):259-66. PubMed ID: 26981177 [TBL] [Abstract][Full Text] [Related]
28. Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness. Patel A; Gyawali CP J Neurogastroenterol Motil; 2019 Apr; 25(2):181-188. PubMed ID: 30827080 [TBL] [Abstract][Full Text] [Related]
29. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463 [TBL] [Abstract][Full Text] [Related]
30. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study. Menon S; Nightingale P; Trudgill N J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868 [TBL] [Abstract][Full Text] [Related]
31. Endoscopic surveillance in Barrett's esophagus. Lunedei V; Bazzoli F; Pozzato P; De Luca L; Zagari RM; Fossi S; Ricciardiello L; Maltoni S; Roda E Minerva Gastroenterol Dietol; 2002 Jun; 48(2):63-71. PubMed ID: 16489297 [TBL] [Abstract][Full Text] [Related]
33. [A Case of Synchronous Multiple Esophageal Cancers Composed of Squamous Cell Carcinoma and Barrett's Adenocarcinoma]. Kobayashi T; Shiozaki A; Fujiwara H; Konishi H; Arita T; Kosuga T; Morimura R; Murayama Y; Komatsu S; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Okamoto K; Otsuji E Gan To Kagaku Ryoho; 2015 Nov; 42(12):1890-2. PubMed ID: 26805207 [TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of Barrett's esophagus-associated neoplasia: circumferential spatial predilection. Ishimura N; Okada M; Mikami H; Okimoto E; Fukuda N; Uno G; Aimi M; Oshima N; Ishihara S; Kinoshita Y Digestion; 2014; 89(4):291-8. PubMed ID: 25059643 [TBL] [Abstract][Full Text] [Related]
35. Red flag imaging in Barrett's esophagus: does it help to find the needle in the haystack? Gonzalez-Haba M; Waxman I Best Pract Res Clin Gastroenterol; 2015 Aug; 29(4):545-60. PubMed ID: 26381301 [TBL] [Abstract][Full Text] [Related]
36. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence. Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140 [TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Jin Z; Mori Y; Yang J; Sato F; Ito T; Cheng Y; Paun B; Hamilton JP; Kan T; Olaru A; David S; Agarwal R; Abraham JM; Beer D; Montgomery E; Meltzer SJ Oncogene; 2007 Sep; 26(43):6332-40. PubMed ID: 17452981 [TBL] [Abstract][Full Text] [Related]
40. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma. Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]